Cortechs.ai

Apr 23, 2025

Cortechs.ai Receives Health Canada Approval to Expand Sales of AI-Powered Imaging Solutions in North America

Nov 20, 2024

Cortechs.ai Announces Oversubscribed Funding Round to Accelerate Innovation in AI-Powered Neuroimaging and Oncology Solutions

Nov 14, 2024

Cortechs.ai Highlights Groundbreaking NeuroQuant® ARIA Technology in Anticipation of Growing Market Demand

Sep 30, 2024

Cortechs.ai Announces Strategic Partnership with Ascend Imaging to Expand Access to Cutting-Edge Radiology Solutions

Sep 03, 2024

Cortechs.ai Receives FDA 510(k) Clearance for Groundbreaking NeuroQuant 5.0 Software, Expanding Support for Quantification of ARIA-E and ARIA-H

Jul 31, 2024

CORTECHS.AI RECEIVES A NEW NIH GRANT FOR ARIA DETECTION IN ALZHEIMER'S DISEASE

May 28, 2024

Cortechs.ai Launches into the Urologic Oncology Market with Novel Prostate Imaging Solution

Apr 24, 2024

Cortechs.ai Announces Major FDA 510(k)-Pending Update to NeuroQuant Software, Expanding Capabilities in Neuroimaging

Jan 14, 2021

Cortechs.ai Introduces New Vice President of Sales